Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
Multiple sclerosis.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Substance Name: Phenytoin
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Venocentric Lesions: An MRI Marker of MS?
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
The role of endogenous antiradical protective system in multiple sclerosis.
A review of the sheep-multiple sclerosis connection.
MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Systematic localization of common disease-associated variation in regulatory DNA.
Dimethyl fumarate - only an anti-psoriatic medication?

Pages